Therapix Biosciences (TRPX) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $0.09 to $0.12
• 50-Day Range: $0.10 to $0.32
• 52-Week Range: $0.25 to $4.69
• Volume: 95,212 shs
• Average Volume: 1.59 million shs
• Market Capitalization: $351,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TRPX Stock Analysis - Frequently Asked Questions

How were Therapix Biosciences' earnings last quarter?

Therapix Biosciences Ltd. (NASDAQ:TRPX) announced its quarterly earnings results on Monday, August, 20th. The company reported ($0.35) earnings per share for the quarter, beating analysts' consensus estimates of ($0.59) by $0.24.

What other stocks do shareholders of Therapix Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Therapix Biosciences investors own include Zynerba Pharmaceuticals (ZYNE), Cara Therapeutics (CARA), Canopy Growth (CGC), Cantel Medical (CMD), Sangamo Therapeutics (SGMO), Corbus Pharmaceuticals (CRBP) and GW Pharmaceuticals (GWPH).

Company Calendar

• Last Earnings: 8/20/2018
• Today: 4/27/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:TRPX
• CIK: 1611746
• Web: therapixbio.com
• Phone: 972-3616-7055
• Fax: N/A
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 3,510,000
• Free Float: N/A
• Market Cap: $351,000.00
• Optionable: Not Optionable
• Beta: N/A